We are live on ! Find out more
PEARW

Pear Therapeutics, Inc. Warrant
PEARW

Delisted

PEARW was delisted on the 18th of April, 2023.

Back to rankings

51 hedge funds and large institutions have $7.97M invested in Pear Therapeutics, Inc. Warrant in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

75% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 4

13% more funds holding

Funds holding: 45 → 51 (+6)

8% less capital invested

Capital invested by funds: $8.62M → $7.97M (-$647K)

Holders
51
Holders Change
+6
Holders Change %
+13.33%
% of All Funds
0.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
7
Reduced
4
Closed
3
Calls
$2.78M
Puts
–
Net Calls
+$2.78M
Net Calls Change
+$20K

Top Buyers

Rank Fund Capital Flow
1
BCM
BlueCrest Capital Management
Jersey
+$347K
2
MF
Magnetar Financial
Illinois
+$299K
3
SRF
Silver Rock Financial
California
+$220K
4
AGM
Alpine Global Management
New York
+$174K
5
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
+$87.4K

Top Sellers

Rank Fund Capital Flow
1
LA
Linden Advisors
New York
-$237K
2
PC
Periscope Capital
Ontario, Canada
-$165K
3
WP
Woodline Partners
California
-$70K
4
CAC
Cowen and Company
New York
-$22K
5
Verition Fund Management
Verition Fund Management
Connecticut
-$4.67K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
26
Ratan Capital Management
Florida
$63K +$69.5K +66,666 New
WCMNY
27
Westchester Capital Management (New York)
New York
$60K +$65.8K +63,181 New
Hudson Bay Capital Management
28
Hudson Bay Capital Management
Connecticut
$52K – – –
PC
29
Periscope Capital
Ontario, Canada
$45K -$165K -157,933 -77%
Blackstone Inc
30
Blackstone Inc
New York
$40K – – –
RCM
31
Rivernorth Capital Management
Florida
$40K +$43.9K +42,089 New
AA
32
AQR Arbitrage
Connecticut
$38K – – –
MI
33
MMCAP International
Cayman Islands
$32K – – –
MIM
34
Monashee Investment Management
Massachusetts
$32K – – –
SCC
35
Spring Creek Capital
Kansas
$32K – – –
TCM
36
Tenor Capital Management
New York
$32K – – –
JP Morgan Chase
37
JP Morgan Chase
New York
$30K – – –
Nomura Holdings
38
Nomura Holdings
Japan
$24K – – –
Parallax Volatility Advisers
39
Parallax Volatility Advisers
California
$18K – – –
HF
40
HRT Financial
New York
$17K +$18.9K +18,111 New
Bank of America
41
Bank of America
North Carolina
$16K – – –
CH
42
CVI Holdings
Delaware
$16K – – –
DCM
43
Dupont Capital Management
Delaware
$16K – – –
Walleye Trading
44
Walleye Trading
New York
$13K – – –
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
$12K +$12.8K +12,305 New
ACM
46
Atalaya Capital Management
New York
$8K – – –
VI
47
Vestcor Inc
New Brunswick, Canada
$8K – – –
UBS Group
48
UBS Group
Switzerland
$3K +$2.98K +2,860 New
CAPTRUST Financial Advisors
49
CAPTRUST Financial Advisors
North Carolina
$2K – – –
Walleye Capital
50
Walleye Capital
New York
$22 – – –
1
2
3

PEARW Hedge Fund Activity: Q3 2021 in Review

51 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Pear Therapeutics, Inc. Warrant (PEARW) for Q3 2021, worth a combined $7.97M — down 7.5% from $8.62M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new PEARW positions and 3 closed out — a net gain of 6 holders — while 7 added to existing stakes and 4 trimmed.

The largest buyer was BlueCrest Capital Management, opening a new position worth an estimated $347K. The largest seller was Linden Advisors, exiting entirely with an estimated $237K sold.

  • 51 institutional investors held Pear Therapeutics, Inc. Warrant (PEARW) as of Q3 2021, up from 45 in Q2 2021.
  • Funds reported $7.97M of Pear Therapeutics, Inc. Warrant stock for Q3 2021, down 7.5% quarter-over-quarter.
  • 9 funds opened new Pear Therapeutics, Inc. Warrant positions in Q3 2021 and 3 closed out, a net change of +6 holders.
  • The largest Pear Therapeutics, Inc. Warrant buyer in Q3 2021 was BlueCrest Capital Management, an estimated $347K added.
  • The largest Pear Therapeutics, Inc. Warrant seller in Q3 2021 was Linden Advisors, an estimated $237K sold.

Based on aggregated 13F filings for Q3 2021.